Opportunities Assessment for Diabetes Therapeutics Market-Taiwan

Publication Date	December 2008
Publisher	Frost & Sullivan
Product Type	Report
Pages	39
ISBN Number	not applicable
Product Code	FRS00880

Buy this product or for assistance call +44 20 7060 7474

PDF £3,605.00$5997 | €4035

FAX Order above formats by FAX

Summary

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Taiwan.

Content

1 Executive Summary
- Overview
  - Executive Summary
2 Diabetes Therapeutics Market
- Market Overview
  - Introduction
  - Context for the Study
  - Research Service Scope and Segmentation
  - Methodology
  - Restraints in Forecasts
3 Taiwanese Diabetes Therapeutics Market
- Market Overview
  - Introduction
  - Market Engineering Measurements
  - Government Initiatives
  - Listing Drugs under the Government Reimbursement Plan
- Market Forecasts and Trends
  - Patient Forecasts
  - Cost of Treatment
- Treatment and Diagnosis
  - Key Treaters
  - Diagnostic Tests
  - Treatment Options
  - Treatment Practice and Glycemic Control
  - Use of Insulin
  - Key Factors/Drivers to Prescribe Insulin
  - Duration of Treatment
  - Product Share by Endocrinologists and GPS
  - Product/Class Launches in 2007 and in future
  - Clinical Trials
- Competitive Analysis
  - Competitive Structure
  - Market Share Analysis
  - Future Trends
  - Challenges Faced by Physicians
4 Appendix
- Taiwan
  - Taiwan